Internal Medicine, Hematology & Oncology · Florham Park, NJ
NPI
1942390869
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
150 Park Ave
Florham Park, NJ, 07932
Phone (973) 538-5210
Groups this clinician bills Medicare through
Medicare paid, 2024
$176K
5,604 services
Medicare patients, 2024
385
Average age 76
Drug cost, 2024
$2.7M
788 prescriptions
Company payments, 2025
$11K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sarada Gurubhagavatula was code 99215 (office e&m - established), 516 times for 173 patients. In total Sarada Gurubhagavatula billed 5,604 services in 64 codes, and Medicare paid $176K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 516 | 173 | $150.69 | $78K |
| 36415 Venipuncture Blood Collection | Office | 500 | 231 | $8.65 | $4,325 |
| 85025 Blood Count | Office | 487 | 228 | $7.55 | $3,676 |
| 80053 Clinical Chemistry | Office | 401 | 220 | $10.25 | $4,109 |
| 83735 Clinical Chemistry | Office | 397 | 224 | $6.50 | $2,582 |
| 84550 Clinical Chemistry | Office | 394 | 223 | $4.39 | $1,728 |
| 84100 Clinical Chemistry | Office | 392 | 222 | $4.60 | $1,804 |
| 99214 Office E&M - Established | Office | 336 | 190 | $104.75 | $35K |
| 83615 Clinical Chemistry | Office | 153 | 111 | $5.88 | $900 |
| 83540 Clinical Chemistry | Office | 141 | 82 | $6.25 | $881 |
| 82728 Clinical Chemistry | Office | 140 | 82 | $13.17 | $1,844 |
| 83550 Clinical Chemistry | Office | 140 | 82 | $8.45 | $1,183 |
| 82306 Clinical Chemistry | Office | 104 | 90 | $29.01 | $3,017 |
| 99233 Hospital E&M - Subsequent | Facility | 99 | 37 | $99.93 | $9,893 |
| 82784 Immunoassay | Office | 69 | 17 | $8.32 | $574 |
By year: 2022 $225K for 10,508 services; 2023 $220K for 9,870 services; 2024 $176K for 5,604 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 500 | 231 | $8.65 | $4,325 |
| 85025 Blood Count | 487 | 228 | $7.55 | $3,676 |
| 80053 Clinical Chemistry | 401 | 220 | $10.25 | $4,109 |
| 83735 Clinical Chemistry | 397 | 224 | $6.50 | $2,582 |
| 84550 Clinical Chemistry | 394 | 223 | $4.39 | $1,728 |
| 84100 Clinical Chemistry | 392 | 222 | $4.60 | $1,804 |
| 83615 Clinical Chemistry | 153 | 111 | $5.88 | $900 |
| 83540 Clinical Chemistry | 141 | 82 | $6.25 | $881 |
| 83550 Clinical Chemistry | 140 | 82 | $8.45 | $1,183 |
| 82728 Clinical Chemistry | 140 | 82 | $13.17 | $1,844 |
Medicare prescription drug claims, 2024
In 2024, the drug Sarada Gurubhagavatula prescribed most often to Medicare patients was Anastrozole, with 149 prescriptions and refills. In total Sarada Gurubhagavatula wrote 788 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 149 | 415 | 43 | $3,823 |
| Eliquis Apixaban | 73 | 109 | 16 | $60K |
| Tagrisso Osimertinib Mesylate | 73 | 73 | Under 11 | $1.2M |
| Hydroxyurea Generic | 49 | 103 | Under 11 | $1,153 |
| Tamoxifen Citrate Generic | 48 | 102 | Under 11 | $915 |
| Letrozole Generic | 41 | 86 | Under 11 | $822 |
| Folic Acid Generic | 33 | 49 | Under 11 | $150 |
| Xarelto Rivaroxaban | 33 | 73 | 11 | $39K |
| Prednisone Generic | 18 | 18 | Under 11 | $125 |
| Nystatin Generic | 18 | 18 | Under 11 | $264 |
| Xalkori Crizotinib | 13 | 13 | Under 11 | $297K |
| Verzenio Abemaciclib | 13 | 13 | Under 11 | $177K |
| Imbruvica Ibrutinib | 13 | 13 | Under 11 | $201K |
| Orserdu Elacestrant Hcl | 13 | 13 | Under 11 | $289K |
| Dexamethasone Generic | 12 | 14 | Under 11 | $320 |
Brand drugs: 272 claims; generic drugs: 516 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sarada Gurubhagavatula $11K ($11K in general payments such as food, travel and fees) from 3 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $11K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 8 | $11K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.